newsfilter
← Latest News
Earnings Call Transcripts·

ULTRAGENYX CONFERENCE CALL - ULTRAGENYX PHARMACEUTICAL INC

Good afternoon and welcome to the Ultragenyx Pharmaceutical Conference Call to discuss the U.S. Food and Drug Administration approval of the FeUV for the treatment of the MPSIIIIA, also known as Sanfilippo Syndrome Type

Company
ULTRAGENYX PHARMACEUTICAL INC
Keywords
ULTRAGENYX PHARMACEUTICAL INC